Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports

Short float is around 40% are we going to see a GME style SS?

March 6 (Reuters) - Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an end to a dispute between the two companies that escalated into a legal battle last month, Bloomberg News reported on Friday.

Hims shares surged 39% in after-hours trading after the report.

[Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports](https://www.msn.com/en-us/health/other/novo-and-hims-to-sell-obesity-drugs-together-as-feud-ends-bloomberg-news-reports/ar-AA1XH7tw?ocid=BingNewsSerp)